Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation

Biochim Biophys Acta. 2010 Mar;1800(3):275-81. doi: 10.1016/j.bbagen.2009.09.005. Epub 2009 Sep 23.

Abstract

Background: Atherosclerosis is one of the major complications of diabetes, which may result from insulin resistance via mitochondrial dysfunction. Although a strong association between insulin resistance and cardiovascular disease has been suggested, it is not clear yet whether stress-inducing factors damage mitochondria and insulin signaling pathway in cardiovascular tissues.

Methods: We investigated whether stress-induced mitochondrial dysfunction might alter the insulin/Akt signaling pathway in A10 rat vascular smooth muscle cells (VSMC).

Results: The treatment of oxidized low density lipoprotein (oxLDL) decreased ATP contents, mitochondrial respiration activity, mRNA expressions of OXPHOS subunits and IRS-1/2 and insulin-mediated phosphorylations of Akt and AMP-activated protein kinase (AMPK). Similarly, dideoxycytidine (ddC), the mtDNA replication inhibitor, or rotenone, OXPHOS complex I inhibitor, inhibited the insulin-mediated pAkt while increased pAMPK regardless of insulin. Reciprocally, an inhibitor of Akt, triciribine (TCN), decreased cellular ATP contents. Overexpression of Akt dominant positive reversed the oxLDL- or ddC-mediated ATP decrease but AMPK activator did not. Akt activation also normalized the aberrant VSMC migration induced by ddC.

Conclusions: Defective insulin signaling and mitochondrial function may collectively contribute to developing cardiovascular disease.

General significance: Akt may be a possible therapeutic target for treating insulin resistance-associated atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Atherosclerosis / pathology
  • Atherosclerosis / physiopathology
  • Cardiovascular Diseases / physiopathology*
  • Cell Movement
  • DNA Primers
  • Electron Transport Complex IV / genetics
  • Humans
  • Insulin / pharmacology
  • Insulin / physiology
  • Lipoproteins, LDL / pharmacology
  • Liver / physiology
  • Mitochondria, Muscle / drug effects
  • Mitochondria, Muscle / metabolism
  • Mitochondria, Muscle / physiology*
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Oxidative Phosphorylation / drug effects
  • Oxygen Consumption
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / physiology
  • Transfection

Substances

  • DNA Primers
  • Insulin
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Adenosine Triphosphate
  • Electron Transport Complex IV
  • Proto-Oncogene Proteins c-akt